NCT01243944 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 110
- group Id
- BG001
- value
- 112
- group Id
- BG002
- value
- 222
- units
- Participants
- groups
- description
- Starting dose of 10 mg BID with individualized dose titration ranging from 5 mg QD to 25 mg BID based on safety and efficacy
- id
- BG000
- title
- Ruxolitinib
- description
- Best Available Therapy (BAT) will be selected by the Investigator for each participant. BAT may not include experimental agents (i.e. those not approved for the treatment of any indication) as well as a limited number of other selected drugs in accordance with the protocol-defined requirements.
- id
- BG001
- title
- Best Available Therapy
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.48
- value
- 61.1
- group Id
- BG001
- spread
- 10.25
- value
- 59.1
- group Id
- BG002
- spread
- 10.39
- value
- 60.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 54
- group Id
- BG002
- value
- 103
- title
- < 60 years
- categories
- measurements
- group Id
- BG000
- value
- 61
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 119
- title
- ≥ 60 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 76
- title
- Female
- measurements
- group Id
- BG000
- value
- 66
- group Id
- BG001
- value
- 80
- group Id
- BG002
- value
- 146
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 98
- group Id
- BG001
- value
- 96
- group Id
- BG002
- value
- 194
- title
- White/Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Black/African American
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 27
- title
- Asian
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 14.09
- value
- 76.6
- group Id
- BG001
- spread
- 17.34
- value
- 79.0
- group Id
- BG002
- spread
- 15.83
- value
- 77.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.44
- value
- 172.2
- group Id
- BG001
- spread
- 9.79
- value
- 173.3
- group Id
- BG002
- spread
- 9.14
- value
- 172.8
- description
- Height was missing at study entry for one participant in the ruxolitinib arm.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 3.82
- value
- 25.8
- group Id
- BG001
- spread
- 4.24
- value
- 26.1
- group Id
- BG002
- spread
- 4.03
- value
- 25.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body Mass Index (BMI)
- unit Of Measure
- kg/m^2
- classes
- categories
- measurements
- group Id
- BG000
- value
- 76
- group Id
- BG001
- value
- 77
- group Id
- BG002
- value
- 153
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 31
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 65
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- title
- 2
- description
- Eastern Cooperative Oncology Group (ECOG) - ECOG Status: 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all selfcare but unable to carry out any work activities up and about more than 50% of waking hours
- param Type
- NUMBER
- title
- ECOG performance status
- unit Of Measure
- participants
- population Description
- All enrolled participants, regardless treated or not.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 110
- group Id
- BG001
- value
- 112
- group Id
- BG002
- value
- 222
- units
- Participants
- groups
- description
- Starting dose of 10 mg BID with individualized dose titration ranging from 5 mg QD to 25 mg BID based on safety and efficacy
- id
- BG000
- title
- Ruxolitinib
- description
- Best Available Therapy (BAT) will be selected by the Investigator for each participant. BAT may not include experimental agents (i.e. those not approved for the treatment of any indication) as well as a limited number of other selected drugs in accordance with the protocol-defined requirements.
- id
- BG001
- title
- Best Available Therapy
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.48
- value
- 61.1
- group Id
- BG001
- spread
- 10.25
- value
- 59.1
- group Id
- BG002
- spread
- 10.39
- value
- 60.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 54
- group Id
- BG002
- value
- 103
- title
- < 60 years
- categories
- measurements
- group Id
- BG000
- value
- 61
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 119
- title
- ≥ 60 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 76
- title
- Female
- measurements
- group Id
- BG000
- value
- 66
- group Id
- BG001
- value
- 80
- group Id
- BG002
- value
- 146
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 98
- group Id
- BG001
- value
- 96
- group Id
- BG002
- value
- 194
- title
- White/Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Black/African American
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 27
- title
- Asian
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 14.09
- value
- 76.6
- group Id
- BG001
- spread
- 17.34
- value
- 79.0
- group Id
- BG002
- spread
- 15.83
- value
- 77.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.44
- value
- 172.2
- group Id
- BG001
- spread
- 9.79
- value
- 173.3
- group Id
- BG002
- spread
- 9.14
- value
- 172.8
- description
- Height was missing at study entry for one participant in the ruxolitinib arm.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 3.82
- value
- 25.8
- group Id
- BG001
- spread
- 4.24
- value
- 26.1
- group Id
- BG002
- spread
- 4.03
- value
- 25.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body Mass Index (BMI)
- unit Of Measure
- kg/m^2
- classes
- categories
- measurements
- group Id
- BG000
- value
- 76
- group Id
- BG001
- value
- 77
- group Id
- BG002
- value
- 153
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 31
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 65
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- title
- 2
- description
- Eastern Cooperative Oncology Group (ECOG) - ECOG Status: 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all selfcare but unable to carry out any work activities up and about more than 50% of waking hours
- param Type
- NUMBER
- title
- ECOG performance status
- unit Of Measure
- participants
- population Description
- All enrolled participants, regardless treated or not.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle